Cannabislandsp. z o.o.

Manufacture of basic pharmaceutical products

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-03-29
Share capital
5,000.00 PLN
Registered address
ul. Stara 13/8, 41-300 Dąbrowa Górnicza, Poland
Electronic delivery address
AE:PL-15320-81995-AABSJ-32

Financials

Revenue history (in k)

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 73 days for 2021).

  • 202514/07/2026
  • 202410/07/2025
  • 202331/07/2024
  • 202206/03/2023
  • 202126/09/2022
  • 202010/05/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 5.24kMedianUSD 164.14kAverageUSD 2.27m
Net profit
This companyUSD -77.72kMedianUSD 1.03kAverageUSD 108.21k
Operating costs
This companyUSD 77.94kMedianUSD 187.05kAverageUSD 2.07m
Assets
This companyUSD 66.28kMedianUSD 115.76kAverageUSD 1.52m

Authorized Representatives

Arkadiusz Loda – President of the Management Board

Manner of representation

In the case of a one-person management board, declarations on behalf of the company are made by a member of the management board. In the case of a management board consisting of two or more persons, each member of the management board is authorised to make declarations on behalf of the company independently.

Ownership

OwnerShare valueStake
$1,350.62100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2019-05-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $3,141.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$391
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$870
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Competitors

Name
Natur DayS.A.
Biotriosp. z o.o.
Nature's Voicesp. z o.o.
Pexon Polandsp. z o.o.
Xenira Pharmaceuticalssp. z o.o.
Bioresearch PharmaS.A.
Sanford Biotechsp. z o.o.
Cefeasp. z o.o.
Auxilius PharmaS.A.
Grupa FinepharmS.A.

Change history

DateEvent
2025-08-22PKD change
2024-08-30Address change
2023-05-15Address change
2019-12-17Address change
2019-12-17Name change

FAQ

Last updated: 2026-10-07